FDAnews
www.fdanews.com/articles/198280-fda-clears-philips-remote-monitoring-defibrillator-platform

FDA Clears Philips’ Remote Monitoring Defibrillator Platform

July 30, 2020

Philips has earned 510(k) clearance from the FDA for its Tempus ALS platform, a remote patient monitoring and defibrillator system.

The system consists of a portable monitor that tracks vital signs and a defibrillator that connect wirelessly to share collected data and images to a web-based software platform.

The device and software platform “will help front line responders provide emergency care, diagnosis and treatment,” including defibrillation therapy and data management, the company said.

View today's stories